ClinConnect ClinConnect Logo
Search / Trial NCT03898141

Animal-assisted Placebo-induced Analgesia

Launched by UNIVERSITY OF BASEL · Mar 29, 2019

Trial Information

Current as of June 24, 2025

Completed

Keywords

ClinConnect Summary

Upon arrival, all participants will be asked to read the study information again and sign to confirm their informed consent. They will also be asked to complete the sociodemographic data (SDD) questionnaire.

During the experiment there will be three points of questionnaire-assessment. The following questionnaires will be used: expectancy will be assessed with the Expectancy of Relief Scale. Expectancy of Relief Scale is adapted to the scaling of the primary outcome. Expectancy has been measured in previous studies. It should detect if participants expectancy changes after the intervention ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Right-handedness
  • Exclusion Criteria:
  • Being scared of dogs or dog hair allergy by self-report
  • Any acute or chronic disease (chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes) as well as skin pathologies, neuropathies or nerve entrapment symptoms, sensory abnormalities affecting the tactile or thermal modality
  • Current medications (psychoactive medication, narcotics, intake of analgesics) or being currently in psychological or psychiatric treatment
  • Insufficient German language skills to understand the instructions
  • Previous participation in studies using pain assessment with Peltier Devices
  • Current or regular drug consumption (THC, cocaine, heroin, etc.)
  • pregnancy
  • nursing women

About University Of Basel

The University of Basel, established in 1460, is one of the oldest and most prestigious universities in Switzerland, renowned for its commitment to research and education in the life sciences, medicine, and clinical research. As a clinical trial sponsor, the university leverages its multidisciplinary expertise and state-of-the-art facilities to advance innovative therapeutic approaches and improve patient care. The University of Basel fosters collaboration among leading scientists, healthcare professionals, and industry partners, ensuring rigorous adherence to ethical standards and regulatory requirements in all clinical trials. Through its comprehensive research programs, the university aims to contribute significantly to the understanding and treatment of various medical conditions, ultimately enhancing global health outcomes.

Locations

Basel, Base Stadt, Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials